Graft Polymer (UK) (LSE:GPL) Equity-to-Asset : 0.83 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Graft Polymer (UK) Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Graft Polymer (UK)'s Total Stockholders Equity for the quarter that ended in Dec. 2023 was £2.03 Mil. Graft Polymer (UK)'s Total Assets for the quarter that ended in Dec. 2023 was £2.43 Mil. Therefore, Graft Polymer (UK)'s Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.83.

The historical rank and industry rank for Graft Polymer (UK)'s Equity-to-Asset or its related term are showing as below:

LSE:GPL' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.49 Med: 0.82 Max: 0.95
Current: 0.83

During the past 6 years, the highest Equity to Asset Ratio of Graft Polymer (UK) was 0.95. The lowest was 0.49. And the median was 0.82.

LSE:GPL's Equity-to-Asset is ranked better than
88.96% of 3025 companies
in the Industrial Products industry
Industry Median: 0.56 vs LSE:GPL: 0.83

Graft Polymer (UK) Equity-to-Asset Historical Data

The historical data trend for Graft Polymer (UK)'s Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Graft Polymer (UK) Equity-to-Asset Chart

Graft Polymer (UK) Annual Data

Trend

May18

May19

May20

May21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.81

0.66

0.49

0.92

0.83

Graft Polymer (UK) Semi-Annual Data
	May18	May19	May20	May21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			0.49	0.97	0.92	0.94	0.83

Competitive Comparison of Graft Polymer (UK)'s Equity-to-Asset

For the Specialty Industrial Machinery subindustry, Graft Polymer (UK)'s Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Graft Polymer (UK)'s Equity-to-Asset Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Graft Polymer (UK)'s Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Graft Polymer (UK)'s Equity-to-Asset falls into.

Graft Polymer (UK) Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Graft Polymer (UK)'s Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2.026	/	2.434
	=	0.83

Graft Polymer (UK)'s Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2.026	/	2.434
	=	0.83

Graft Polymer (UK) (LSE:GPL) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Graft Polymer (UK) Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Graft Polymer (UK)'s Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Graft Polymer (UK) (LSE:GPL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Graft Polymer (UK) PLC (LSE:GPL) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

J4I:Germany

Address

Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF

Website

https://www.graftpolymer.com

Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment.

Graft Polymer (UK) (LSE:GPL) Headlines

No Headlines